Henry Ford Health

Henry Ford Health Scholarly Commons
Neurosurgery Articles

Neurosurgery

9-2-2020

Risk Factors Associated with Symptomatic Deep Vein
Thrombosis Following Elective Spine Surgery: A Case-Control
Study
Thomas M. Zervos
Henry Ford Health, TZERVOS1@hfhs.org

Michael Bazydlo
Henry Ford Health, mbazydl1@hfhs.org

Kelly M. Tundo
Henry Ford Health, KCIACH1@hfhs.org

Mohamed Macki
Henry Ford Health, mmacki2@hfhs.org

Jack Rock
Henry Ford Health, jrock1@hfhs.org

Follow this and additional works at: https://scholarlycommons.henryford.com/neurosurgery_articles

Recommended Citation
Zervos TM, Bazydlo M, Tundo K, Macki M, and Rock J. Risk Factors Associated With Symptomatic Deep
Vein Thrombosis Following Elective Spine Surgery: A Case Control Study. World Neurosurg 2020.

This Article is brought to you for free and open access by the Neurosurgery at Henry Ford Health Scholarly
Commons. It has been accepted for inclusion in Neurosurgery Articles by an authorized administrator of Henry
Ford Health Scholarly Commons.

Original Article

Risk Factors Associated with Symptomatic Deep Vein Thrombosis Following Elective
Spine Surgery: A CaseeControl Study
Thomas M. Zervos1, Michael Bazydlo2, Kelly Tundo1, Mohamed Macki1, Jack Rock1

BACKGROUND: Few studies provide insight into risk
factors (RFs) associated with postoperative deep vein
thrombosis (DVT) following elective spinal surgery. DVTs
are detrimental in this population because of the risk of
pulmonary embolization or surgical site hemorrhage with
treatment.

-

OBJECTIVE: Elective spine surgery patients have a low
incidence of DVT, thus a caseecontrol study was selected
to investigate RFs associated with postoperative, symptomatic DVT.

higher risk of developing symptomatic DVT postoperatively
resulting in significantly increased length of stay. Further
studies on additional preoperative screening and medical
optimization in elective spine surgery patients may help
reduce the rate of symptomatic, postoperative DVT.

-

METHODS: Cases were matched to controls in a 1:2 ratio
based on surgery type. Risk of having a prior DVT and
choice of subcutaneous heparin dosing following surgery
was analyzed in a multivariate regression model with other
potentially confounding variables.

-

RESULTS: A total of 195 patients were included in this
study. Independent of patient age, history of DVT was
associated with postoperative symptomatic DVT (odds ratio
[OR], 4.09; 95% confidence interval [CI], 1.22e13.78). Two
versus 3 times daily postoperative heparin dosing (OR, 1.56;
95% CI, 0.32e7.56), surgery length (OR, 1.32; 95% CI, 0.98e
1.79), and patient age (OR, 1.04; 95% CI, 1.0e1.08) were not
statistically significant, independent RFs. Older age and
longer length of surgery trended toward association with
DVT without reaching significance. Length of stay was
increased from 3e5 days (P < 0.001) in DVT patients
compared with controls.

-

CONCLUSIONS: These results suggest that patients with
a history of DVT undergoing elective spinal surgery are at

-
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INTRODUCTION
Background/Rationale
reatment of deep vein thrombosis (DVT) following spinal
surgery can be particularly challenging because of the
added risk of therapeutic anticoagulation following
neurosurgical procedures. Retrospective studies in the neurosurgical literature report a 0.85%e32% risk of postoperative DVT and
a rate of <1% epidural hemorrhage postoperatively in spine surgery patients.1-4 A contemporary estimate of DVTs in patients
receiving chemotherapeutic prophylaxis is 0.2%e7%, with higher
rates likely occurring in more invasive procedures, such as
deformity surgery.5-7 Overall, there is a 6.4% risk of 30-day mortality in patients with venous thromboembolism.8 Prophylactic
measures, such as chemoprophylaxis and use of pneumatic
compression devices, can vary between surgeons and
institutions as there are no high-quality studies that investigate
the beneﬁts of these interventions in the context of spine surgery.
Further characterization of the risk factors (RFs) associated with
DVT formation after spinal surgery might allow speciﬁc interventions that target these high-risk subgroups.
Both the Neurocritical Care Society and the CHEST physician
guidelines recommend initiation of chemoprophylaxis after spine
surgery once the surgeon judges the beneﬁt to outweigh the
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potential harm.9,10 Based on large cohort studies, a practice of
starting 5000 U of subcutaneous heparin on postoperative day 1
likely has a favorable riskebeneﬁt ratio.2,5-7 However, variation
in DVT prevention practices is dependent on patient-speciﬁc
concerns and provider preferences.
Objective
There is currently no risk stratiﬁcation algorithm available to help
guide timing and dosing of chemoprophylaxis after neurosurgical
procedures. The purpose of this caseecontrol study is to identify
RFs associated with development of symptomatic DVTs requiring
treatment. This could help identify patients at the greatest risk of
DVT and guide practice patterns. The selection of RFs was based
on review of variables found to be associated with DVT in other
patient populations.11 In particular, asymptomatic DVT leading to
subsequent symptomatic DVT is a well-established occurrence in
hospitalized patients.12 This has not speciﬁcally been tested in the
elective spine surgery population.

METHODS
Study Design
A caseecontrol study was conducted in accordance with the
STROBE (Strengthening the Reporting of Observational Studies in
Epidemiology) criteria.13 The study was approved by our
institutional review board (IRB#10557). Institutional review
board approval for waiver of patient consent was met in
accordance with the Health Insurance Portability and
Accountability Act, Privacy Rule, Section 164.512.
Setting
Cases and controls were identiﬁed using the Michigan Spine
Surgery Improvement Collaborative (MSSIC), a collaborative
quality initiative. Speciﬁc details regarding MSSIC data collection
protocols and deﬁnitions are provided by Chang et al.14 This is an
adult population of lumbar and cervical spinal surgery for
stenosis, disc herniation, and degenerative disease. Data were
collected from 2014e2017.
Participants
A total of 65 DVT cases were identiﬁed in this time period. Surgery
for tumors, traumatic fractures, deformity, scoliosis, and acute
spinal cord injury are currently not within the scope of MSSIC. No
cases within the MSSIC dataset occurring in this time period were
excluded.
Controls were patients without an identiﬁed DVT in the postoperative period. Lower extremity ultrasounds were not obtained
on asymptomatic controls. A total of 130 controls were matched in
a 1:2 ratio based on procedure type (arthrodesis and/or laminectomy), cervical versus lumbar location, exact number of levels,
and date of surgery (þ/e 1 month). If more than 2 controls
matched a case, 2 were randomly selected to be included in this
study. Matching criteria were determined a priori. Cases and
controls were drawn from a total study population of 4431
patients.
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Variables
Cases were identiﬁed as having a new blood clot on venous duplex
ultrasound, venogram, or computed tomography scan within 90
days postoperatively. Venous ultrasound was performed at the
discretion of the treating physician. History of DVT is deﬁned as
documented by primary care physician or anywhere in the history.
Information regarding outcome, exposure, confounders, and effect modiﬁers for variables are provided in prior publications.14
Data Sources
Retrospective chart review was performed to obtain information
regarding heparin dose and timing, intraoperative platelet
administration, perioperative (within 24 hours before or after
surgery) glucocorticoid administration, and peripherally inserted
central catheter/central line use. Retrospective chart review was
performed by one author and veriﬁed by a second author. Data
sources for the remaining variables are provided in prior publications.14 Cases and controls were taken from the same
population.
Bias
The retrospective nature of this study introduces information bias.
Patients were contacted 3 times postoperatively as part of the
MSSIC initiative, however, they were not speciﬁcally asked about
DVT after discharge. For example, it is possible that a patient was
treated at an outside hospital for a DVT and was misclassiﬁed.
Also, lower extremity ultrasounds were only obtained on patients
who exhibited clinical symptoms consistent with DVT. It is
possible that patients with asymptomatic DVT in the control group
were not identiﬁed. Also, the number of patients with asymptomatic DVT preoperatively could not be ascertained.
Study Size
A simulation was run to estimate the power of the study to detect a
statistically signiﬁcant association between heparin dose timing
and the likelihood of postoperative DVT at several hypothetical
odds ratios (ORs) (Figure 1). The process was performed by
simulating data for the covariates used in the logistic regression
model for a population of 25,000 patients. The associations
between these covariates and DVT were set to levels similar to
those obtained by the model run on the real data in our sample,
and an intercept was chosen to control the rate of DVT in the
simulated population. A total of 500 random samples of 65
cases and 130 controls were then drawn from the population.
The proportion of statistically signiﬁcant ORs for heparin dose
timing from the logistic models represented the estimated
power. This process was repeated 50 times and the power
estimates of each run were averaged to smooth uncertainty from
the samples.
Quantitative Variables
Summary measures of patient and surgical characteristics were
compared between patients who experienced a DVT postoperatively and those that did not. The c2 tests were used for
categorical variables, t-tests were used for normally distributed
variables, and the Wilcoxon rank-sum tests were used for variables
with skewed distributions. For categorical variables with cell
counts too small for the c2 tests, the Fisher’s exact test was used.
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Main Results
Based on prior studies, known RFs for DVT were tested in a
multivariate analysis to test for confounder-adjusted estimates. In
multivariate analysis, history of DVT was the only RF to reach
statistical signiﬁcance (Table 2). Independent of patient age,
history of prior DVT was associated with symptomatic
postoperative DVT (OR, 4.09; 95% conﬁdence interval [CI],
1.22e13.78). Two versus 3 times daily postoperative heparin
dosing (OR, 1.56; 95% CI, 0.32e7.56), surgery length (OR, 1.32;
95% CI, 0.98e1.79), and patient age (OR, 1.04; 95% CI, 1.0e
1.08) were not statistically signiﬁcant. Older age and longer
length of surgery had a trend toward association with DVT
formation.
There was 1 case of postoperative spinal hematoma requiring
reoperation. This occurred in a patient who was started on aspirin
81 mg and heparin 5000 U every 8 hours on postoperative day 1
due to cardiovascular RFs. After a prolonged recovery, he/she
returned to his/her preoperative baseline.
Figure 1. Power simulation for heparin dosing for prevention of deep vein
thrombosis (DVT). A simulation model was run to estimate the power of the
study to detect a statistically significant association between heparin dose
timing and likelihood of postoperative DVT at several hypothetical odds ratios
(ORs). These results suggest that an adequately powered study would not be
feasible to detect an effect of 10% as suggested in the literature using the
current study design.

Statistical Methods
A multivariable Firth-logistic regression model was also constructed to evaluate the association between heparin dose timing
and postoperative DVT, adjusting for age, history of DVT, length
of surgery, spine location (cervical vs. lumbar), number of levels,
and procedure type (fusion vs. decompression alone). This type of
model is interpreted in the same way as a regular logistic model
but it helps handle issues that can arise when sets of predictor
variables almost completely separate cases from controls. Multivariable analysis was performed on complete cases.
RESULTS
Participants
Of the 195 patients, there was 100% participation and 3-year
follow-up data for age, sex, body mass index, American Society
of Anesthesiologists grade, history of DVT, EuroQuol-5D surveys,
spine location, blood loss, drain use, surgery length, and length of
stay (LOS). Information on heparin dose and timing, glucocorticoid use, peripherally inserted central catheter or central line, and
platelet transfusion was available for 117 patients.
Descriptive/Outcome Data
Baseline characteristics for the patients in our study are provided
in Table 1. Baseline age (P ¼ 0.002), history of DVT (P < 0.001),
and LOS (P < 0.001) were found to be different between the 2
groups. Lovenox was used as a postoperative chemoprophylaxis
in 1 patient. There was a trend toward signiﬁcance of
developing a DVT in the patients who received a perioperative
platelet transfusion (P ¼ 0.097, 7% vs.14%). Other potential RFs
were not found to be statistically signiﬁcantly different (Table 1).
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DISCUSSION
Key Results
Established RFs for developing DVT in the neurosurgical patient
population include the presence of either benign or malignant
tumors, spinal cord injury, head trauma, hemorrhagic or ischemic
stroke, duration of surgery, and decreased mobility or limb
movement.15 After elective spinal procedures, retrospective cohort
studies have identiﬁed the following associations with
postoperative DVT: previous DVT, postoperative urinary tract
infection, creatinine >2.0 mg/dL, presence of an inferior vena
cava ﬁlter, longer hospital stay, surgery type, and presence of a
spinal fracture.6,16 These factors all directly or indirectly impact
blood ﬂow stasis, endothelial injury, and/or hypercoagulability.
Postoperative DVT speciﬁcally following elective spinal surgery is
less well studied, partly because of the lower incidence of DVT
in this population. Based on the Neurocritical Care Society and
the CHEST Physician guidelines, the lack of rigorously
developed and extensively validated models of DVT risk in welldeﬁned surgical populations limits the authors’ ability to make
evidence-based recommendations.9,10
During the time period of this study, heparin was the chemoprophylactic agent of choice for patients undergoing elective spine
surgery at our institution. This practice is supported by literature
suggesting that there is no signiﬁcant difference in the rate of DVT
or postoperative hematoma in patients treated with lowmolecular-weight heparin versus unfractionated heparin after
similar procedures.17 Furthermore, in a survey of
chemoprophylaxis techniques among North American surgeons,
there was equivalent use of low-molecular-weight heparin and
unfractionated heparin after degenerative/deformity surgery.18
Prospective, randomized controlled trials are warranted to
further compare these practice patterns in the context of elective
spine surgery.
The dosing and timing of subcutaneous heparin following spine
surgery is controversial. Because of the risk of spinal epidural
hematoma, some advocate for no chemoprophylaxis and when it
is used, the dose can vary between providers.6 In one retrospective
study, in which heparin dosing was variable between providers,
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Table 1. Pre- and Postoperative Baseline Characteristics
Characteristic
Age

Summary Measure

No DVT (N [ 135)

DVT (N [ 65)

P Value

Mean þ/e SD

61.1 þ/e 12.3

65.5 þ/e 12.1

0.002

Male

Count (%)

66 (49%)

37 (57%)

0.287

BMI

Mean þ/e SD

30.6 þ/e 5.7

31.6 þ/e 7.1

0.293

Count (%)

14 (20%)

10 (32%)

0.195

ASA grade >2

Count (%)

93 (69%)

48 (74%)

0.472

History of DVT

Count (%)

7 (6%)

15 (29%)

<0.001

Not anxious/depressed

Count (%)

27 (34%)

14 (39%)

0.156

Moderately anxious/depressed

Count (%)

46 (57%)

15 (42%)

Extremely anxious/depressed

Count (%)

7 (9%)

7 (19%)

Aspirin within 7 days of surgery

EQ-5D anxiety/depression

EQ-5D pain
No pain

Count (%)

3 (4%)

4 (11%)

Moderate pain

Count (%)

37 (45%)

18 (49%)

Extreme pain

Count (%)

42 (51%)

15 (41%)

Some problems walking

Count (%)

11 (14%)

5 (14%)

No problems walking

Count (%)

69 (85%)

31 (86%)

0.261

EQ-5D mobility

Confined to bed

>0.999

Count (%)

1 (1%)

0 (0%)

Count (%)

108 (80%)

57 (88%)

0.234

Subcutaneous 5000 U Q8 hours

Count (%)

21 (20%)

14 (26%)

0.393

Subcutaneous 5000 U Q12 hours

Count (%)

82 (80%)

39 (74%)

Chemoprophylaxis
Heparin dose timing

Mean þ/e SD

157.4 þ/e 39.1

149.0 þ/e 44.3

0.433

Glucocorticoid use

Count (%)

91 (68%)

47 (72%)

0.528

VTE prophylaxis

Count (%)

134 (99%)

65 (100%)

>0.999

PICC or central line

Count (%)

0 (0%)

7 (22%)

>0.999

Platelet transfusion

Count (%)

9 (7%)

9 (14%)

0.097

Lumbar

Count (%)

87 (64%)

42 (65%)

0.981

Cervical

Heparin per 24 hours per kg

Spine location

Count (%)

48 (36%)

23 (35%)

Fusion

Count (%)

87 (64%)

43 (66%)

0.812

Multiple levels

Count (%)

96 (72%)

47 (72%)

0.985

Median (IQR)

2.5 (1.0, 5.8)

3.5 (1.5, 7.0)

0.152

Count (%)

88 (65%)

41 (63%)

0.770

Length of surgery (hours)

Median (IQR)

2.2 (1.5, 3.2)

2.5 (1.8, 3.6)

0.142

Length of stay (days)

Median (IQR)

3.0 (2.0, 4.0)

5.0 (3.0, 8.8)

<0.001

Blood loss (50 cc)
Drain left in place postoperatively

DVT, deep vein thrombosis; SD, standard deviation; BMI, body mass index; ASA grade, American Society of Anesthesiologists grade; EQ-5D, EuroQuol-5D; VTE, venous thromboembolism; PICC,
peripherally inserted central catheter; IQR, interquartile range.
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Table 2. Multivariable Logistic Regression (n ¼ 117)
Variable

OR (95% CI)

P Value

Subcutaneous 5000 U Q8

Referent

-

Subcutaneous 5000 U Q12

1.56 (0.32, 7.56)

0.562

Age (years)

1.04 (1.00, 1.08)

0.054

History of DVT

4.09 (1.22, 13.78)

0.014

Surgery length (hours)

1.32 (0.98, 1.79)

0.052

Lumbar

Referent

-

Cervical

1.27 (0.48, 3.36)

0.618

Multiple levels

0.56 (0.21, 1.52)

0.243

Arthrodesis

0.89 (0.29, 2.73)

0.836

Heparin dose timing

Spine location

OR, odds ratio; CI, confidence interval; DVT, deep vein thrombosis.

standardization of heparin to 5000 U 3 times daily, resulted in a
statistically signiﬁcant decrease in thrombotic complications
without increasing the number of patients with bleeding
complications.7 To our knowledge, this is the only other study
to look at the effect of postoperative spine surgery heparin dosing.
By utilizing a caseecontrol study design and matching based on
surgical procedure, we sought to identify additional RFs. The
caseecontrol study design is a preferable method over cohort
studies when an event is uncommon.19 In spine surgery-speciﬁc
studies, the risk of DVT has been shown to be associated with
invasiveness of procedure, ambulatory status, and malignancy.4,20
Matching patents by procedure type nulliﬁed the invasiveness of
the procedure as a confounding RF.
At our institution, subcutaneous heparin is historically the
preferred chemotherapeutic agent due to its short half-life, ability
for reversal, and well-established safety proﬁle. To speciﬁcally test
the signiﬁcance of postoperative heparin dosing, a power analysis
was performed for this variable based on existing literature.
Despite the caseecontrol study design, we found that the estimated sample number to reach a power of 0.8 was not feasible due
to an inadequate sample size and estimated effect size of 10%
based on the ﬁndings in other publications (Figure 1).8
The identiﬁcation of preexisting RFs for DVT formation allows
surgeons to be informed when implementing preventative measures. From an administrative perspective, LOS was increased
from an average of 3 to 4 days postoperatively. Six of the patients
who developed a DVT required an inferior vena cava ﬁlter placement postoperatively. Fortunately, the treatment of DVT for patients in this study did not lead speciﬁcally to postoperative
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